← FDA Drug Approvals (Drugs@FDA)
ENJAYMO
BLA · Biologics License Application · Sponsor: RECORDATI RARE DISEASES, INC. · Approved 2022-02-04
Drug application
- FDA Application #
BLA761164- Application type
- Biologics License Application
- Brand name
- ENJAYMO
- Generic name
- SUTIMLIMAB-JOME
- Active ingredients
- SUTIMLIMAB-JOME
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- RECORDATI RARE DISEASES, INC.
- Manufacturer
- Recordati Rare Diseases, Inc.
- First approval
- 2022-02-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown